Sarepta Therapeutics (SRPT) stock — price, news and analysis
Sarepta Therapeutics (SRPT) trades on US markets (NASDAQ / NYSE). Track its live price and interactive chart below; the latest SRPT news will be collected here as it is published.
Catalystsby D-day
FOMC = U.S. Fed official schedule · expiry = US options/futures (3rd Friday)
Latest US market news
No SRPT-specific stories yet — here's what's moving the US market. All US news ›
AbbVie Skyrizi Wins Pediatric Psoriatic Disease Label, Extending Post-Humira Runway (ABBV)
Jun 26, 2026
Meta Explores Polymarket and Kalshi Integration: What It Means for META Stock
Jun 26, 2026
Indivior (INDV) Breaks Out on IBD 50 as Institutional Funds Accumulate
Jun 26, 2026
PayPal PYUSD Stablecoin Strategy: Payments Moat or Competitive Gamble? (PYPL)
Jun 26, 2026
Oil Contango Deepens on Rising Hormuz Flows, Signaling Near-Term Supply Glut
Jun 26, 2026
AI Spending Credibility Cracks: Tech Posts One of Its Worst Weeks in a Year
Jun 26, 2026
Profit Taking Tests U.S. Equity Rally Depth as Positioning Grows Extended
Jun 26, 2026
U.S. Strike on Iran Lifts Oil After Three-Week Slide: XOM, CVX, COP in Focus
Jun 26, 2026SRPT — frequently asked
What is the SRPT stock price today?
The live Sarepta Therapeutics (SRPT) price and an interactive chart are shown at the top of this page, updated in real time during US market hours (9:30 AM – 4:00 PM ET) and at the last close otherwise.
Where is SRPT listed?
Sarepta Therapeutics (SRPT) is a US-listed equity traded on the NASDAQ / NYSE. It belongs to the 바이오 sector.
Is the latest SRPT news bullish or bearish?
We are not tracking SRPT news right now. New stories will appear in the news section below as they are published.
Prices are delayed outside US market hours and provided for information only — not investment advice. Sarepta Therapeutics (SRPT) news is produced from public information.